SNDX - Syndax Pharmaceuticals GAAP EPS of -$0.62 beats by $0.04
- Syndax Pharmaceuticals press release ( NASDAQ: SNDX ): Q4 GAAP EPS of -$0.62 beats by $0.04 .
- As of December 31, 2022, Syndax had cash, cash equivalents, short-term and long-term investments of $481.3 million and 69.3 million common shares and prefunded warrants outstanding.
For further details see:
Syndax Pharmaceuticals GAAP EPS of -$0.62 beats by $0.04